Activation of the PI3K/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib

Press/Media: Research

Period	Mar 8 2024

Media coverage

Title	Activation of the PI3K/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib
Media name/outlet	MOLECULAR CANCER
Country/Territory	United Kingdom
Date	3/8/24
URL	https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-024-01965-5
Persons	Xiaoming Wang, Jianmin Wang